Abb. 3 CheckMate-066: Nivolumab verbessert im Vergleich zu Chemotherapie das Gesamtüberleben von Patienten mit fortgeschrittenem Melanom signifikant [5]
German derma 2-4
This site is only for use by healthcare professionals. By continuing to view this site you are confirming that you are a healthcare professional.